The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
Aim. To study the effect of rivaroxaban compared with warfarin on the incidence of cardioembolic stroke and systemic thromboembolic complications (TEC), bleeding in patients with non-valvular atrial fibrillation (AF).Material and methods. Patients (n=126) older than 18 years, appealed to the Cardiol...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2016-11-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/1336 |